HBIO vs WYNN · rev $22.7M vs P/E 29, rev $7.14B
Harvard Bioscience Inc (HBIO) versus Wynn Resorts Limited (WYNN) — a side-by-side from cached financials, not a winner call.
Harvard Bioscience Inc (HBIO) is a medical instruments & supplies company listed on US.
Wynn Resorts Limited (WYNN) is a resorts & casinos company listed on NASDAQ.
Latest reported HBIO revenue for 2026-06-30 was $22.7M. Net income was -$2.9M. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. HBIO currently screens at market cap $20.3M.
Latest reported WYNN revenue for 2025-12-31 was $7.14B. Net income was $327.3M. WYNN currently screens at market cap $10.62B and trailing P/E 29.3.
HBIO currently screens at market cap $20.3M. WYNN currently screens at market cap $10.62B and trailing P/E 29.3.
Not investment advice. Open the HBIO and WYNN stock pages for the full models.
Not investment advice.